| receptors, purinergic p2 | A class of cell surface receptors for purines that prefer ATP or ADP over adenosine. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. Subtypes have been proposed, usually designated p2 x, y, z, and t. P2x receptors may mediate fast synaptic transmission by ATP. The ADP-preferring p2t receptors in platelets stimulate aggregation. (12 Dec 1998) |
|---|---|
| receptors, retinoic acid | Proteins in the nucleus or cytoplasm that specifically bind retinoic acid or retinol and trigger changes in the behaviour of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognised. (12 Dec 1998) |
| receptors, sensory | Specialised neurons or parts of neurons which transduce sensory information and relay it centrally. Included are receptors for stimuli outside the body (exteroceptors) as well as receptors for stimuli from within the body itself (interoceptors and proprioceptors). Sensory receptors may include accessory structures which condition (e.g., filter) the input received by the receptor neurons themselves. (12 Dec 1998) |
| receptors, serotonin | Cell-surface proteins that bind serotonin and trigger intracellular changes which influence the behaviour of cells. Several types of serotonin receptors have been recognised which differ in their pharmacology, molecular biology, and mode of action. (12 Dec 1998) |
| receptors, sigma | A class of cell surface receptors recognised by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues. (12 Dec 1998) |
| receptors, somatomedin | Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behaviour of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes. (12 Dec 1998) |
| receptors, somatostatin | Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behaviour of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter. (12 Dec 1998) |
| receptors, somatotropin | Cell surface proteins that bind somatotropin with high affinity and trigger intracellular changes influencing the behaviour of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. (12 Dec 1998) |
| receptors, steroid | Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behaviour of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. (12 Dec 1998) |
| receptors, tachykinin | Cell surface proteins that bind tachykinins with high affinity and trigger intracellular changes influencing the behaviour of cells. Three classes of tachykinin receptors have been characterised, the nk-1, nk-2, and nk-3, which prefer, respectively, substance p, neurokinin a (substance k, neurokinin alpha, neuromedin l), and neurokinin b (neurokinin beta, neuromedin k). (12 Dec 1998) |
| receptors, thrombin | Cell surface proteins that specifically bind thrombin and trigger changes in the behaviour of blood cells. There are at least two types of thrombin receptors on platelets. The higher affinity receptors mediate the inhibition of stimulated adenylate cyclase, the secretion of acid hydrolases, and the activation of phospholipase a2. The lower affinity receptors are linked to phospholipase c and trigger platelet aggregation and exposure of fibrinogen binding sites. A human platelet thrombin receptor has been cloned and is a member of the family of peptide receptors. There are also thrombin receptors on endothelial cells and smooth muscle cells. (12 Dec 1998) |
| receptors, thromboxane | Cell surface proteins that bind thromboxanes with high affinity and trigger intracellular changes influencing the behaviour of cells. at least a subset of thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems. (12 Dec 1998) |
| receptors, thyroid hormone | Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erba, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erba proteins act as growth suppressors. The c-erba proteins are encoded by at least two genes, c-erba alpha and c-erba beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes thyroid hormone resistance syndrome. (12 Dec 1998) |
| receptors, thyrotropin | Cell surface proteins that bind thyrotropin and trigger intracellular changes influencing the behaviour of cells. These receptors are present in the nervous system and on cells in the thyroid gland. Autoantibodies to these receptors are implicated in graves', hashimoto's, and other thyroid diseases. (12 Dec 1998) |
| receptors, thyrotropin-releasing hormone | Cell surface receptors that bind thyrotropin releasing hormone (trh) with high affinity and trigger intracellular changes which influence the behaviour of cells. Activated trh receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, tsh). Trh receptors on neurons mediate neurotransmission by trh. (12 Dec 1998) |
Synonyms : M4 Receptor, Muscarinic, M4 Receptors, Muscarinic, M4, Muscarinic Receptor, M4, Muscarinic Receptors, Muscarinic M4 Receptor, Muscarinic M4 Receptors, Receptor M4, Muscarinic, Receptors M4, Muscarinic
Synonyms : M5 Muscarinic Receptor, Receptors, Muscarinic M5, M5 Receptor, Muscarinic, M5 Receptors, Muscarinic, M5, Muscarinic Receptor, M5, Muscarinic Receptors, Muscarinic M5 Receptor, Muscarinic M5 Receptors, Muscarinic Receptor, M5, Receptor M5, Muscarinic
Synonyms : GP80-LNGFR, Neurotrophin Receptor p75, Neurotropin Receptor p75, gp75 NGFR, p75 Neurotrophin Receptor, GP80 LNGFR, NGFR, gp75, Nerve Growth Factor Receptor, Low Affinity, Neurotrophin Receptor, p75, Receptor p75, Neurotrophin, Receptor p75, Neurotropin
Synonyms : Notch1 Protein
Synonyms : Notch2 Protein
| reciprocal |
the flip of a fraction when dividing fractions
출처: library.thinkquest.org/5196/Workpages/definitions....
|
|---|---|
| reconstruction |
Surgery to rebuild the shape of the breast.
출처: www.ehealthmd.com/library/breastcancer/BRC_glossar...
|
| reconstructive surgery |
This type of surgery is done to repair or correct abnormalities caused by disease, injury, birth defects, other surgeries, or infections. The goal is to restore function and sometimes restore appearance.
출처: www.ehealthmd.com/library/eyelidsurgery/ES_glossar...
|
| recurrence |
Reappearance of the cancer; also known as relapse. There are three kinds of recurrence: local - at the same site; regional - near the original site; and distant - in another site.
출처: www.ehealthmd.com/library/breastcancer/BRC_glossar...
|
| reconstructive surgery |
A procedure performed to restore a bodily function, or to correct a deformity resulting from disease, injury, trauma, congenital anomalies or developmental abnormalities, or previous medically necessary treatment (eg, surgery, radiation therapy). The characteristics to be corrected are considered to be outside the range of normal. Examples of such conditions include cleft lip, deforming birthmarks and burn scars.
출처: https://www.capbluecross.com/FAQs/Glossary+of+Term...
|
| REC | a port city of northeastern Brazil on the Atlantic |
|---|---|
| REC | directions for making something |
| REC | the semantic role of the animate entity that is passively involved in the happening denoted by the verb in the clause |
| REC | a person who gets something |
| REC | the semantic role of the animate entity that is passively involved in the happening denoted by the verb in the clause |
| REC | (math) one of a pair of numbers whose product is 1: the reciprocal of 2/3 is 3/2 |
| REC | concerning each of two or more persons or things |
| REC | a method of behavior therapy based on the inhibition of one response by the occurrence of another response that is mutually incompatible with it |
| REC | a unit of conductance equal to the reciprocal of an ohm |
| REC | a method of behavior therapy based on the inhibition of one response by the occurrence of another response that is mutually incompatible with it |
| REC | a relation of mutual dependence or action or influence |
| REC | in an inverse or contrary manner |